L.A. Officials Complain There Aren’t Enough Firefighters – After Firing Hundreds Who Refused to Take COVID Vaccine

As fires rage across Los Angeles, city officials are complaining there are not enough firefighters to manage the situation.

Speaking at a press conference on Wednesday, Los Angeles County Fire Chief Anthony Marrone said that the department was incapable of managing such a massive natural disaster.

“There are not enough firefighters in all of Los Angeles County to address four separate fires of this magnitude,” he said.

“The LA County Fire Department was prepared for one or two major wildfires, but not the four. This is not a normal red flag alert.”

While their lack of manpower is completely understandable given the incredible ferocity of the fires, it is worth noting that many firefighters were fired for their refusal to take the COVID vaccine.

As pointed out by the popular End Wokeness account X, local news media even ran reports back in 2021 about how firefighters had their employment terminated after refusing to provide proof of vaccination or requesting an exemption.

Keep reading

Pfizer’s secret documents reveal that their COVID vaccine actually made you 8.7% more likely to get COVID

Pfizer tested all participants in their Phase 3 trial for N-antibodies. The results were kept hidden from the public. It was only through court order that we finally know what the results were.

Do you think they would have kept this data secret from the public if it showed good news? Heck no!

The table showed that Pfizer only had around 50% protection if you just take the table at face value. But if you interpret the table correctly, it shows Pfizer had negative efficacy.

In this article, I’ll show you how to properly interpret that data and get the truth.

The method was first disclosed by Jikkyleaks on May 24, 2022.

I recently became aware of it after independently replicating his work. I believe his numbers are slightly off, so I’ll show you the proper calculation for the correct estimate of the case counts.

No doubt about it; those who took the shots were more likely to be infected by COVID by 8.7%.

There is just no other way to interpret the Pfizer data. It’s “gold standard” clinical trial data.

The overall counts are too small for the result to be statistically significant. But the FDA should NEVER be approving a vaccine where the primary endpoint efficacy (reducing cases vs. the unvaccinated group) is so small to be statistically insignificant.

In plain English, the best estimates are that there were actually more infections in the vaccine group than the placebo group. Whoops!

This is a major failing of the FDA to recognize this.

It won’t be long before Senator Ron Johnson brings this to their attention.

Keep reading

DNA Contamination Study — Conducted at FDA Lab by Students Supervised by FDA Scientists — ‘Doesn’t Belong to FDA’ Agency Says

The U.S. Food and Drug Administration (FDA) has responded to a peer-reviewed study conducted within its own laboratory, which uncovered excessively high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine.

The study revealed that residual DNA levels exceeded regulatory limits by six to 470 times, validating earlier studies from independent researchers that the FDA had previously disregarded.

Published by students in the Journal of High School Science, the study has garnered significant attention since the story broke, with its altimetric score rivaling those of major studies in leading medical journals.

Despite the study being conducted at the FDA’s White Oak campus in Maryland, the agency has sought to distance itself from the findings.

A spokesperson stated that the study “does not belong to the FDA” and is therefore not theirs to disclose.

“The FDA does not comment on individual studies,” the spokesperson added, declining to acknowledge the new scientific findings.

The agency also refused to address the involvement of three of its own scientists — Shuliang Liu, Ph.D., Tony Wang, M.D., and Prabhuanand Selvaraj, Ph.D. — who supervised the students conducting the study.

When questioned about potential regulatory actions, such as issuing a public alert, recalling affected vaccine batches, or notifying other agencies, the FDA stood firm in its defense of mRNA vaccine safety.

Keep reading

Unmasking the Contamination Crisis in mRNA Injectable Drugs: A Public Health Catastrophe in the Making

The alarm bells began to ring loudly when Kevin McKernan first uncovered alarmingly high levels of DNA contamination in early 2023, a finding that has since been corroborated by numerous independent scientists. The most recent revelation comes from a study conducted in a laboratory utilized by the FDA itself, exposing staggering levels of contamination in every analyzed vaccine lot. This discovery, particularly significant because of the FDA’s connection, suggests that the problem may be even worse than initially reported. Methodological limitations raise the possibility that larger, more dangerous DNA fragments capable of disrupting cellular functions remain undetected. Instead of taking responsibility, the FDA—the agency charged with safeguarding public health—has chosen to distance itself from these damning findings. By denying ownership of the study and refusing to act, the FDA has demonstrated a chilling disregard for public safety, prioritizing perception over accountability.

DNA contamination, even in small fragments, is far from a hypothetical risk confined to theoretical science. These fragments can trigger immune pathways like cGAS-STING,[1] leading to chronic inflammation and immune system dysregulation. The threat of genomic integration—where foreign DNA integrates into human cells—looms ominously, with potentially catastrophic consequences if it occurs in critical regions such as oncogenes or tumor suppressor genes. This risk is compounded by the lipid nanoparticles (LNPs) used in vaccine delivery, which protect these fragments and enhance their ability to enter human cells. The very mechanism designed to deliver the mRNA payload efficiently may inadvertently pave the way for these fragments to wreak havoc within the human body.

The FDA laboratory’s report indicated that the DNA contamination consisted of non-replicating fragments, which might appear less dangerous at first glance. The probability of genomic integration was estimated at approximately 1 in 10 million cells. While this figure may sound reassuringly small, the broader context reveals a much more alarming reality. The human body contains roughly 37 trillion cells, meaning that even such a low probability translates to an average of around 3,700 cells per individual potentially experiencing genomic integration. If foreign DNA integrates into critical genomic regions in just one of these cells,[2] the results could be catastrophic, leading to mutations that may escape immune detection and cause severe health outcomes over time.

When scaled to the billions of vaccinated individuals worldwide, the potential for population-wide health impacts becomes staggering. The sheer number of affected cells across global populations magnifies the risk of rare but severe reactions, challenging the dismissive assurances of safety provided by regulatory bodies. These are not merely theoretical risks; they are statistically plausible outcomes that demand immediate scrutiny and decisive action. The scale and scope of these potential outcomes should compel regulatory agencies and manufacturers to halt vaccine distribution until these dangers are fully understood and mitigated.

Keep reading

Over 160,000 Skin Issues Reported to V-Safe After COVID-19 Vaccination

When the COVID-19 vaccines rolled out, CDC provided a V-safe app where people could record their symptoms. The attorneys who represent ICAN sued CDC to release this data. The V-safe data revealed over 124,000 reports of rashes; 22,000 reports of hives; 11,000 reports of blisters; 3,000 reports of eczema; 2,500 reports of psoriasis; and 1,500 reports of lesions. Some examples in the vaccine recipients’ own words:

  • “Severe hives. Started the morning of 1/11 went to urgent care 1/12 at 3am. Raised and red hives. Started on thighs and arms. Eventually covered 90% of my body.”
  • “Bullous lesions on hands. Slow healing process. Had a biopsy of one of the lesions.”
  • “6 silver dollar sized psoriasis like patches on my chest and ive [sic] never had any skin issues in my life”
  • “Had very unusual rapid growing lesion, biopsy done 1/15/21. Suspecting autoimmune process. Requires topical and systemic pain meds.”
  • “Painful blisters on my hands, feet, wrists and elbows as well as in my nostril.”
  • “Ulcers on roof of mouth and down throat (not something that has ever happened to me before)”
  • “Rash all over, hive like bumps on palms of feet and hands, back, stomach, legs, arms, its every where [sic] and very itchy.”

Scientific literature includes many reports of cutaneous (skin) reactions after COVID-19 vaccination. Most skin reactions to drugs are considered to be a hypersensitive immune response involving mast cells, and the preferred treatment is to discontinue the drug.

Keep reading

Bill Gates unleashes plan for new series of gene-based injections that will target Africa

Microsoft co-founder Bill Gates is rolling out a plan to use Africans as guinea pigs for an expanded series of new genetically altering mRNA injections.

He calls them vaccines but we know they are not vaccines, at least not in the traditional meaning of the word. U.S. courts have even ruled that mRNA serums don’t qualify as vaccines.

The Covid vaccines, the first to use this technology, have been an unmitigated disaster.

But that hasn’t stopped Gates from pushing more of these gene-based jabs on the world.

The Bill & Melinda Gates Foundation has announced a $40 million initiative to support the production of messenger mRNA vaccines in Africa.

Gates’ foundation claims this investment will address what it refers to as “vaccine inequities” exposed during the COVID-19 pandemic.

During that pandemic, African nations were often the last to receive Covid jabs. It worked to their benefit as fewer Africans died of Covid, per capita than Westerners.

Yet, the power of money never ceases and so Gates presses on in his efforts to vaccinate the world against every disease imaginable. And Africa will be ground zero for the plan.

Gates and his foundation hope to expand the testing of the mRNA injections on Africans before they are rolled out globally.

Keep reading

A Young Child Died During Moderna Covid Vaccine Clinical Trial — Did FDA Know?

A preschool-aged child died of cardio-respiratory arrest after getting a COVID-19 booster in a Moderna clinical trial. However, Moderna didn’t reveal the death to the public and only recently reported it on a European regulatory agency database, Alex Berenson reported.

The death occurred in late 2022 or early 2023, Berenson said, when children under 5 who had already received Moderna’s original mRNA-1273 COVID-19 vaccine in the trial’s main phase were offered the “1273.214” booster against an early Omicron variant.

Berenson, a former New York Times reporter who now reports on his Unreported Truths Substack, today said the U.S. Food and Drug Administration (FDA) has declined to tell him whether the U.S. agency knew that a child died during Moderna’s clinical trial.

The failure of the FDA to provide a straightforward answer about whether it knew that a young child in a Moderna clinical trial died from cardiac-respiratory arrest is “vitally important,” Berenson told The Defender.

“Of all the mistakes public health authorities made around COVID, their insistence on pressing mRNA vaccines on children was probably the worst,” Berenson said.

By the time the COVID-19 vaccines were available for kids, it was clear that children were at almost no risk of serious illness or death from COVID-19, he said. “The shots had significant side effects, so the only rationale for giving them shots — even theoretically — was to reduce transmission.”

Keep reading

Drones Spray ‘Self-Spreading’ COVID-19 Vaccine for ‘Large-Area Inoculation of Humans’ in ‘DEFUSE’ EcoHealth/DARPA Project

  • EcoHealth’s DEFUSE Proposal Exposed: In 2018, EcoHealth Alliance submitted a proposal to DARPA, codenamed DEFUSE, outlining plans to deploy aerosolized immune modulators, chimeric spike proteins, and/or self-spreading vaccines via drones, potentially over humans.
  • Aerosolized Vaccination on Humans: DEFUSE documents explicitly describe large-area aerosol delivery systems for “inoculation of animals/humans,” raising the question of whether these plans were executed on unsuspecting populations.
  • Drone Deployment and Pandemic Origin: The DEFUSE proposal and DARPA’s advanced drone programs suggest a chilling possibility: that drones may have played a role in the COVID-19 pandemic, challenging the mainstream lab-leak narrative.
  • DARPA’s Connection to Moderna: By 2012, DARPA was already working with Moderna on RNA-based spike protein vaccines. A 2016 Moderna patent contains a genetic sequence with a one-in-3-trillion match to the pandemic virus, igniting claims of bioengineering origins.
  • Suppression of DEFUSE Details: Whistleblower revelations show attempts by DARPA and intelligence agencies to classify and censor DEFUSE-related research. U.S. senators have demanded investigations into these actions.
  • Self-Spreading Vaccines and Gain-of-Function: DEFUSE documents reveal plans for self-disseminating vaccines and host-to-host therapeutic distribution, indicating the potential use of engineered viruses as vaccine delivery systems.
  • Unprecedented Drone Funding Surge: A 26% spike in military drone funding in 2019 aligns with DEFUSE’s timeline and its drone-based aerosol delivery technologies, hinting at pre-pandemic preparations.
  • International Drone Use During COVID-19: Governments worldwide deployed drones for “disinfecting,” but studies debunk the effectiveness of this practice, raising suspicion about the true purpose of these operations.
  • A Coordinated Bioengineering Agenda?: The alignment of DEFUSE, DARPA, and drone advancements reveals an unsettling intersection of gain-of-function research, bioweaponized delivery systems, and self-spreading vaccines.
  • Urgent Transparency Needed: The DEFUSE project raises alarming questions about the origins of COVID-19, the ethics of aerosolized bioengineering, and the U.S. government’s role in these developments. The public deserves truth and accountability, especially considering a potentially incoming bird flu pandemic.

Keep reading

More Big Pharma/Big Government Attacks Coming – Arepanrix: Package Insert & Approval Letter

By now, readers know this writer is a staunch advocate for proper informed consent following the informed consent process. Previously, the injectable vaccine AUDENZ for H5N1 manufactured by Seqirus was reviewed to inform the public about the product. While it was a long read, the package insert for AUDENZ proved there were not enough participants to represent the population, placebo-controlled trials were only conducted in one study, and the one-year follow-up was not long enough to uncover potential serious adverse events relating to development of autoimmune diseases. Understandably, reading package inserts is not particularly “attention-grabbing” and can be quite boring and tedious. However, it is the only way you will receive all the information you need to give proper informed consent, which includes denying taking a product. Because of the volume of data to be covered in the AREPANRIS package insert, it will be covered in two parts.

In this article, the approval letter and package insert for AREPANRIX will be reviewed. The only approval letter for AREPANRIX on the Food and Drug Administration (FDA) website is dated October 18, 2024. This letter references another letter dated April 19, 2024, which requested a supplement to their license regarding packaging to include the proprietary name of AREPANRIX. There should be another letter indicating the initial FDA approval for this vaccine. Without the initial approval letter, there is no additional information to be gleaned besides the package insert.

AREPANRIX, manufactured by GlaxoSmithKline (GSK), is approved for active immunization for the prevention of disease caused by the Influenza A virus H5N1 subtype contained the vaccine for individuals 6 months and older. AREPANRIX comes in two vials that must be mixed before administration: one contains the H5N1 antigen and the other contains the AS03 adjuvant. The AS03 adjuvant will be explained in Part II. For individuals ages 6 months through 17 years, two doses of 0.25 ml are injected intramuscularly 21 days apart. For individuals ages 18 years and older, two doses of 0.5 ml are injected intramuscularly 21 days apart. (Sections 1 through 2.2)

Keep reading

COVID Vaxx Team Trialing Bubonic Plague Vaccine as Fears of Next Pandemic Grow

British scientists who worked on the Astrazeneca COVID-19 jab are calling for the UK to stockpile vaccines for the bubonic plague, as fears about the next global pandemic grow.

Britain’s Daily Telegraph reports that scientists with the Oxford Vaccine Group are worried the UK could be caught unprepared by a global pandemic of the disease which killed tens of millions of people the Middle Ages.

The Oxford Vaccine Group has been trialling a plague vaccine since 2021, on a group of 40 healthy adults. The group’s leader, Professor Sir Andrew Pollard, says the vaccine has proven a success, and results of the trial will be submitted to a scientific journal for peer review within weeks. Further clinical trials are expected.

Pollard said: “There are no licensed plague vaccines in the UK. Antibiotics are the only treatment. There are some licensed vaccines in Russia.

“The risk in the UK is currently very low. Previous historical pandemics that had high mortality were associated with initiation from fleas on rodents but were driven by person to person spread.”

Military scientists in the UK believe the plague, which still exists in isolated pockets around the world, has the “potential for pandemic spread.” Scientists from the UK government’s biological research facility at Porton Down recently wrote a paper claiming that vaccine production needs to be enhanced “to prevent future disastrous plague outbreaks.”

Keep reading